MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2
M.-Z. Pan, Y.-L. Song, F. Gao Department of Urology Surgery, The Seventh People’s Hospital of Jinan, Jinan, China.
We detected some serious inaccuracies and mistakes. Therefore, the article “MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2, by M.-Z. Pan, Y.-L. Song, F. Gao, published in Eur Rev Med Pharmacol Sci 2019; 23 (20): 8795-8805–DOI: 10.26355/eurrev_201910_19274–PMID: 31696466” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadMiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
M.-Z. Pan, Y.-L. Song, F. Gao
MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 5
Pages: 2156-2156
DOI: 10.26355/eurrev_202103_25197